Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$6.26 - $9.34 $643,146 - $959,582
102,739 Added 38.99%
366,230 $2.8 Million
Q3 2022

Nov 14, 2022

SELL
$6.5 - $12.67 $202,592 - $394,898
-31,168 Reduced 10.58%
263,491 $1.88 Million
Q2 2022

Aug 11, 2022

BUY
$6.4 - $14.73 $956,761 - $2.2 Million
149,494 Added 102.98%
294,659 $2.38 Million
Q1 2022

May 13, 2022

BUY
$10.12 - $28.9 $311,159 - $888,588
30,747 Added 26.87%
145,165 $2.02 Million
Q4 2021

Feb 11, 2022

BUY
$25.17 - $36.85 $818,629 - $1.2 Million
32,524 Added 39.71%
114,418 $3.21 Million
Q3 2021

Nov 09, 2021

BUY
$30.02 - $39.87 $690,580 - $917,169
23,004 Added 39.06%
81,894 $2.78 Million
Q2 2021

Aug 11, 2021

BUY
$32.22 - $44.59 $420,728 - $582,256
13,058 Added 28.49%
58,890 $2.41 Million
Q1 2021

May 13, 2021

BUY
$37.26 - $67.74 $588,857 - $1.07 Million
15,804 Added 52.63%
45,832 $1.85 Million
Q3 2020

Nov 13, 2020

SELL
$35.79 - $48.81 $675,070 - $920,654
-18,862 Reduced 38.58%
30,028 $1.46 Million
Q2 2020

Aug 06, 2020

BUY
$24.95 - $48.38 $102,494 - $198,745
4,108 Added 9.17%
48,890 $2.37 Million
Q1 2020

May 15, 2020

BUY
$16.96 - $34.16 $759,502 - $1.53 Million
44,782 New
44,782 $1.24 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.